Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Multiple Myeloma

1-anilino-8-naphthalenesulfonate has been researched along with Multiple Myeloma in 6 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research Excerpts

ExcerptRelevanceReference
"A 71-year-old woman, known to have multiple myeloma, was admitted because of fever, abdominal pain and hyperamylasaemia and hyperamylasuria."1.29Hyperamylasaemia in multiple myeloma. ( Bloemendal, HJ; Lobatto, S, 1996)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arosio, P1
Owczarz, M1
Müller-Späth, T1
Rognoni, P1
Beeg, M1
Wu, H1
Salmona, M1
Morbidelli, M1
Matsui, T1
Higashimoto, Y1
Yamagishi, S1
Bloemendal, HJ1
Lobatto, S1
Nair, S1
Sachan, P1
Hertan, H1
Pitchumoni, CS1
Feussner, G1
von Hodenberg, E1
Ziegler, R1
Shihabi, ZK1
Bishop, C1

Other Studies

6 other studies available for 1-anilino-8-naphthalenesulfonate and Multiple Myeloma

ArticleYear
In vitro aggregation behavior of a non-amyloidogenic λ light chain dimer deriving from U266 multiple myeloma cells.
    PloS one, 2012, Volume: 7, Issue:3

    Topics: Amyloid; Anilino Naphthalenesulfonates; Cell Line, Tumor; Circular Dichroism; Humans; Hydrogen-Ion C

2012
Laminin receptor mediates anti-inflammatory and anti-thrombogenic effects of pigment epithelium-derived factor in myeloma cells.
    Biochemical and biophysical research communications, 2014, Jan-17, Volume: 443, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Cell Line, Tumor; Chemokine CCL2; Eye Proteins; Fibrinolytic Agen

2014
Hyperamylasaemia in multiple myeloma.
    The Netherlands journal of medicine, 1996, Volume: 49, Issue:1

    Topics: Aged; Amylases; Diagnosis, Differential; Fatal Outcome; Female; Humans; Lipase; Multiple Myeloma; Pa

1996
Metastatic multiple myeloma with hyperamylasaemia and hyperlipasaemia.
    Postgraduate medical journal, 1998, Volume: 74, Issue:876

    Topics: Amylases; Female; Humans; Lipase; Middle Aged; Multiple Myeloma

1998
Atypical type III hyperlipoproteinemia in a patient with Ig A myelomatosis.
    Klinische Wochenschrift, 1990, May-17, Volume: 68, Issue:10

    Topics: Cholesterol, VLDL; Female; Humans; Hyperlipoproteinemia Type III; Immunoglobulin A; Lipase; Lipoprot

1990
Simplified turbidimetric assay for lipase activity.
    Clinical chemistry, 1971, Volume: 17, Issue:12

    Topics: Acute Disease; Acute Kidney Injury; Amylases; Bile Acids and Salts; Blood Urea Nitrogen; Cholecystit

1971